Anticoagulant Citrate Dextrose A Acd-a Injection, Solution
NDC Package 43203-852-47

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anticoagulant Citrate Dextrose A Acd-a injection is classified as a

administered via extracorporeal route. This formulation utilizes a injection, solution delivery system. Marketed by Arteriocyte Medical Systems, Inc., this product is identified by NDC 43203-852 and is authorized under FDA application BA110057.

Identification & Billing

NDC Package Code
43203-852-47
Package Description
50 POUCH in 1 CASE / 1 BAG in 1 POUCH / 50 mL in 1 BAG
Product Code
43203-852
11-Digit Billing Format
43203085247

Clinical Specifications

Proprietary Name
Anticoagulant Citrate Dextrose A Acd-a
Non-Proprietary Name
Anticoagulant Citrate Dextrose A Acd-a
Substance Name
Citric Acid Monohydrate; Dextrose Monohydrate; Sodium Citrate, Unspecified Form
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Extracorporeal - Administration outside of the body.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Arteriocyte Medical Systems, Inc.
Product Type
Human Prescription Drug
FDA Application #
BA110057
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-11-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43203-852-47 identifies a specific commercial package of 50 pouch in 1 case / 1 bag in 1 pouch / 50 ml in 1 bag of Anticoagulant Citrate Dextrose A Acd-a, a human prescription drug labeled by Arteriocyte Medical Systems, Inc.. This injection, solution is formulated for extracorporeal use and contains citric acid monohydrate; dextrose monohydrate; sodium citrate, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Arteriocyte Medical Systems, Inc. on May 11, 2011. The current certification is valid through December 31, 2026.

How is this Arteriocyte Medical Systems, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43203085247. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43203-852-47
11-Digit CMS (5-4-2)
43203-0852-47

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.